Follow-up research of JVC-001 Phase III Study (Specific Clinical Research)
Not Applicable
Recruiting
- Conditions
- ot applicableNot applicable
- Registration Number
- JPRN-jRCTs031230590
- Lead Sponsor
- Shindo Shizuo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 861
Inclusion Criteria
Participation in the study participants who have obtained the voluntary written consent from the father, mother, grandfather, or grandmother of the study subjects and who satisfy the following inclusion criteria and do not violate the exclusion criteria are eligible.
Inclusion criteria
1) those who have been enrolled in the J301 trial and received the clinical trial vaccine
2) those who have been judged by the principal investigator or co-investigator to have no problems participating in this study
Exclusion Criteria
1) those who have received an additional dose of combined measles-rubella vaccine (MR vaccine) or mumps vaccine
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method